Mosmoris Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 27.25%
- Profit Growth 22.51%
- Ebitda 16.18%
- Net Worth 2.24%
- Total Assets -3.16%
About Mosmoris Pharmaceuticals
Mosmoris Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 October 2017 (Seven years and three months 25 days old ). Its registered office is in Siwan, Bihar, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Brij Devi and Abhishek Ranjan serve as directors at the Company.
Company Details
-
Location
Siwan, Bihar, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999BR2017PTC036066
-
Company No.
036066
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Oct 2017
-
Date of AGM
30 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Mosmoris Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Ranjan
|
Managing Director | 20-Oct-2017 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Brij Devi
|
Director | 20-Oct-2017 | Current |
Financial Performance of Mosmoris Pharmaceuticals.
Mosmoris Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 27.25% increase. The company also saw a substantial improvement in profitability, with a 22.51% increase in profit. The company's net worth moved up by a moderate rise of 2.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mosmoris Pharmaceuticals?
Unlock access to Mosmoris Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Locus Pharma Private LimitedBrij Devi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mosmoris Pharmaceuticals?
Unlock and access historical data on people associated with Mosmoris Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mosmoris Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mosmoris Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.